Venture-Backed Startups
125,331 companies with verified investor relationships.
Bioflyte provides chemical and biological threat detection solutions for critical infrastructure and business operations, enabling organizations to monitor, identify and respond to bio/chem threats. The company serves government agencies, critical infrastructure operators, and other organizations responsible for security and safety.
4 investors
Biofourmis provides technology-enabled solutions and a platform for AI-driven in-home patient care, using wearable biosensors and remote monitoring to deliver and transition patients across levels of care. It serves healthcare providers and partners, aiming to reduce hospital readmissions and cost of care.
1 investor
Biofrontera develops treatments for actinic keratosis and other common skin conditions, aimed at improving outcomes for dermatology patients and providers. The company operates in the pharmaceutical and dermatology space.
0 investors
BiofuelCircle operates an online marketplace and supply chain platform connecting the biomass and biofuel value chain, from farm to fuel, for buyers and sellers of biomass commodities. The platform hosts a range of agricultural and biofuel commodities and facilitates their trade and logistics.
1 investor
0 investors
BioGaia is a Swedish probiotics company that develops, manufactures, markets, and sells probiotic products based on L. reuteri strains for gut, immune, and oral health. It focuses on microbiome research and serves healthcare professionals and consumers, selling products in around 100 countries.
1 investor
Biogaran is a French pharmaceutical brand focused on generic medicines and health products, offering health-related content and patient support initiatives. It serves patients and caregivers in France with wellness information and community programs.
1 investor
Biogazelle provides genomic and transcriptomic laboratory services from ISO17025-accredited and GCLP-compliant labs, supporting research, diagnostics, therapeutics, and clinical trials. It serves scientists and clinicians working in personalized medicine.
1 investor
Biogea develops agrotechnology products based on beneficial fungi and bacteria to increase crop yields for agricultural producers in a sustainable way. The company serves farmers with biological inputs marketed under brands including BIOGROW3 and Nitro Aire.
1 investor
Biogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
3 investors
BIOGENA develops premium micronutrient supplements, functional drinks, and longevity services for consumer health and wellness across different life stages. The company manufactures products in Austria focused on scientific efficacy, purity, and quality standards.
1 investor
0 investors
Biogenera develops DNA-based anti-gene oligonucleotide drugs using PNA (Ag-PNA) to silence altered genes that cause serious diseases, including aggressive pediatric tumors such as neuroblastoma via its BGA002 candidate targeting the MYCN gene. The pharmaceutical biotech company operates its patented MyGenera platform to identify precision-medicine gene therapies for cancers and rare diseases.
1 investor
BioGeneration Ventures is a venture capital investor focused on early-stage biotech and life sciences companies. It works with a network of universities, startups, and large pharmaceutical companies to build and accelerate product development.
3 investors
0 investors
0 investors
BioGlitz develops biodegradable, sustainable glitter as an alternative to conventional plastic glitter, marketed for self-expression and use in fashion and beauty. The company positions its products around environmental awareness and responsible use.
1 investor
Biograil is a pre-clinical stage pharmaceutical company developing technology to convert injectable pharmaceutical products into oral capsules. It operates in the drug delivery and pharmaceutical development sector.
1 investor
Biograph runs membership-based preventive health clinics that combine whole-body MRI, blood biomarkers, cardiac and brain imaging, DEXA scans and other diagnostics in a single-day assessment to detect early risk of heart disease, cancer, metabolic dysfunction and neurodegenerative disease. Physicians review the results with members and provide personalized recommendations and follow-up care, with clinics in San Mateo and New York City.
2 investors
Biographica (Graphica) uses multi-modal machine learning and high-throughput sequencing to identify and prioritize genetic targets for crop gene-editing, working with trait developers to design effective edits. It serves agricultural biotech companies developing more productive, nutritious, and climate-resilient crops.
4 investors
1 investor
0 investors
BioGrip develops non-invasive neuromuscular sensing technology combined with adaptive AI to decode human intention and enable intuitive control of prosthetics, rehabilitation systems, and robotics. The company targets individuals with mobility impairments and muscular or peripheral nerve damage.
2 investors
Biogroup is a network of medical biology laboratories that provides diagnostic testing and lab services to patients. It emphasizes proximity and quality of care across its locations in France.
1 investor